C07C 239/04
N-halogenated amines
C07C239/04 (N-halogenated amines) appears on 12 US grants and 5 published applications in this corpus.
Search patents in C07C- Granted patents
- 12
- Published applications
- 5
- Assignees
- 9
- Inventors
- 23
- Latest grant
- 9 Aug 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 2 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 1 | 0 |
| 2015 | 0 | 1 |
| 2016 | 2 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Process for preparing chloroamines9 Aug 2016US 9,409,863 B2Bayer Intellectual Property GmbH
- Substituted N,N-dihaloamines as antimicrobials2 Feb 2016US 9,248,117 B2NovaBay Pharmaceuticals, Inc.
- Adamantane derivatives possessing anti-viral and anti-microbial activity16 Sep 2014US 8,835,507 B2Vymed Corporation
- Octafluoropentaerythrityltetramine (octafluoro-peta) and process for its preparation30 Aug 2011US 8,008,527 B1The United States of America as represented by the Secretary of the Navy
- N,N-dihalogenated amino acids and derivatives22 Feb 2011US 7,893,109 B2NovaBay Pharmaceuticals, Inc.
- Process for preparing chloroamines22 Jan 2015US 2015/0025245 A1Bayer Intellectual Property GmbH
- Adamantane derivatives possessing anti-viral and anti-microbial activity5 Sep 2013US 2013/0231391 A1Vymed Corporation
- Antimicrobial Polyether and Polyol Compounds24 May 2012US 2012/0129793 A1NovaBay Pharmaceuticals, Inc.
- N,n-dihalogenated amino acids and derivatives22 Jan 2009US 2009/0023812 A1NovaBay Pharmaceuticals, Inc.
- N,N-dihalogenated amino acids and derivatives24 Mar 2005US 2005/0065115 A1NovaBay Pharmaceuticals, Inc.
Most cited
By later US patents
- N,N-dihalogenated amino acids and derivatives5US 7,893,109 B2NovaBay Pharmaceuticals, Inc. · 2011
- Derivatives of N-chloro-N-methyl glucamine and N-chloro-N-methyl glucamine esters4US 5,985,239 AUniversity of Kentucky Research Foundation · 1999
- Process for the preparation of chloroamines3US 5,070,200 AOlin Corporation · 1991
- Process for preparing hydrazines2US 4,677,227 A1987
- Neopentyl difluoroamino compounds for use in energetic formulations2US 5,789,617 AAerojet-General Corporation · 1998